Tonix Pharmaceuticals Holding Corp (TNXP) concluded trading on Thursday at a closing price of $14.63, with 16.0 million shares of worth about $234.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.86% during that period and on March 06, 2025 the price saw a gain of about 33.49%. Currently the company’s common shares owned by public are about 155.63M shares, out of which, 5.59M shares are available for trading.
Stock saw a price change of 78.85% in past 5 days and over the past one month there was a price change of -3.81%. Year-to-date (YTD), TNXP shares are showing a performance of -55.64% which decreased to -98.79% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.76 but also hit the highest price of $1216.00 during that period. The average intraday trading volume for Tonix Pharmaceuticals Holding Corp shares is 1.65 million. The stock is currently trading 43.26% above its 20-day simple moving average (SMA20), while that difference is down -37.24% for SMA50 and it goes to -79.75% lower than SMA200.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) currently have 155.63M outstanding shares and institutions hold larger chunk of about 2.86% of that.
The stock has a current market capitalization of $81.79M and its 3Y-monthly beta is at 2.16. It has posted earnings per share of -$20.56 in the same period. It has Quick Ratio of 2.78 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TNXP, volatility over the week remained 30.11% while standing at 19.88% over the month.
Stock’s fiscal year EPS is expected to rise by 95.88% while it is estimated to increase by 45.37% in next year. EPS is likely to shrink at an annualized rate of 78.59% for next 5-years, compared to annual growth of 79.31% made by the stock over the past 5-years.
Coverage by ROTH Capital stated Tonix Pharmaceuticals Holding Corp (TNXP) stock as a Buy in their note to investors on April 18, 2019, suggesting a price target of $4 for the stock. Stock get an Outperform rating from Oppenheimer on February 17, 2016.
